Vanda Pharmaceuticals Announces Participation at November 2022 Investor Conferences

Rhea-AI Summary

Vanda Pharmaceuticals Inc. (VNDA) announced its participation in upcoming investor conferences in November 2022. The company will present at the Stifel 2022 Healthcare Conference on November 15 at 10:20 a.m. Eastern Time, and at the Jefferies 2022 London Healthcare Conference on November 17 at 12:20 p.m. Greenwich Mean Time (7:20 a.m. Eastern Time). Live access to these presentations will be available on Vanda's corporate website, with archived versions accessible for about 30 days.

Positive

• Participation in notable investor conferences may enhance visibility.
• Opportunities for networking with potential investors and stakeholders.

Negative

• None.

WASHINGTON, Nov. 8, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in November 2022:

The Stifel 2022 Healthcare Conference on Tuesday, November 15, 2022. A corporate presentation is scheduled for 10:20 a.m. Eastern Time.

The Jefferies 2022 London Healthcare Conference on Thursday, November 17, 2022. A corporate presentation is scheduled for 12:20 p.m. Greenwich Mean Time (7:20 a.m. Eastern Time).

The corporate presentations given at the Stifel and Jefferies conferences may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the links under Recent Events. Investors are advised to go to the conference websites at least 15 minutes early to register, download, and install any necessary software or presentations. Links to the archived conferences will be available on Vanda's website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on Twitter @vandapharma.

Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

View original content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-november-2022-investor-conferences-301672344.html

SOURCE Vanda Pharmaceuticals Inc.

FAQ

What investor conferences will Vanda Pharmaceuticals participate in November 2022?

Vanda Pharmaceuticals will participate in the Stifel 2022 Healthcare Conference on November 15 and the Jefferies 2022 London Healthcare Conference on November 17.

What time will Vanda Pharmaceuticals present at the investor conferences?

Vanda's presentation at the Stifel Conference is scheduled for 10:20 a.m. Eastern Time, and at the Jefferies Conference for 12:20 p.m. Greenwich Mean Time (7:20 a.m. Eastern Time).

How can investors access Vanda Pharmaceuticals' presentations?

Investors can access the presentations live on Vanda's corporate website under the Investors tab, with archived versions available for approximately 30 days.

What is the significance of Vanda Pharmaceuticals' participation in these conferences?

Participation in these conferences can enhance investor visibility and provide opportunities to engage with potential stakeholders.